IL-1β enhances vascular smooth muscle cell proliferation and migration via P2Y2 receptor-mediated RAGE expression and HMGB1 release

Vascular Pharmacology

Volumn 72, Issue , 2015, Pages 108-117

  Eun, So Young ^a   Ko, Young Shin ^a   Park, Sang Won ^a   Chang, Ki Churl ^a   Kim, Hye Jung ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

HMGB1; IL 1 ; P2Y2 nucleotide receptor; Proliferation; RAGE; Vascular smooth muscle cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADVANCED GLYCATION END PRODUCT RECEPTOR; CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE C; PURINERGIC P2Y2 RECEPTOR; RAC1 PROTEIN; RHO KINASE; ROCK2 PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; URIDINE TRIPHOSPHATE; AGER PROTEIN, RAT; HBP1 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; CYTOSOL; GENE SILENCING; GENETIC TRANSFECTION; MEDIATOR; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; STRESS FIBER; VASCULAR SMOOTH MUSCLE CELL; ANIMAL; ATHEROSCLEROSIS; CELL CULTURE; CELL MOTION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RAT; SMOOTH MUSCLE CELL; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ADVANCED GLYCOSYLATION END PRODUCT-SPECIFIC RECEPTOR; ANIMALS; ATHEROSCLEROSIS; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; HMGB1 PROTEIN; INTERLEUKIN-1BETA; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; RATS; RECEPTORS, PURINERGIC P2Y2; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84939566423     PISSN: 15371891     EISSN: 18793649     Source Type: Journal    
DOI: 10.1016/j.vph.2015.04.013     Document Type: Article

References (44)

1. Libby P., Ridker P.M., Hansson G.K. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009, 54:2129-2138.
2. Isenovic E.R., Kedees M.H., Haidara M.A., Trpkovic A., Mikhailidis D.P., Marche P. Involvement of ERK1/2 kinase in insulin-and thrombin-stimulated vascular smooth muscle cell proliferation. Angiology 2010, 61:357-364.
3. Newby A.C. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 2006, 69:614-624.
4. Rakesh K., Agrawal D.K. Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells. Int Immunopharmacol 2005, 5:1487-1506.
5. Doran A.C., Meller N., McNamara C.A. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008, 28:812-819.
6. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 1996, 87:2095-2147.
7. Gordon J.L. Extracellular ATP: effects, sources and fate. Biochem J 1986, 233:309-319.
8. Vassort G. Adenosine 5'-triphosphate: a P2 purinergic agonist in the myocardium. Physiol Rev 2001, 81:767-806.
9. Seye C.I., Kong Q., Erb L., Garrad R.C., Krugh B., Wang M., et al. Functional P2Y2 nucleotide receptors mediate uridine 5'-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 2002, 106:2720-2726.
10. 2 purinoceptor in intimal lesions of the rat aorta. Arterioscler Thromb Vasc Biol 1997, 17:3602-3610.
11. Seye C.I., Yu N., González F.A., Erb L. Weisman GA/ The P2Y2 nucleotide receptor mediates vascular cell adhesion molecule-1 expression through interaction with VEGF receptor-2 (KDR/Flk-1). J Biol Chem 2004, 279:35679-35686.
12. Hou M., Möller S., Edvinsson L., Erlinge D. Cytokines induce upregulation of vascular P2Y(2) receptors and increased mitogenic responses to UTP and ATP. Arterioscler Thromb Vasc Biol 2000, 20:2064-2069.
13. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., et al. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005, 83:876-886.
14. Ballinger M.L., Thomas M.C., Nigro J., Ivey M.E., Dilley R.J., Little P.J. Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cells. Kidney Int 2005, 68:2756-2765.
15. Burke A.P., Kolodgie F.D., Zieske A., Fowler D.R., Weber D.K., Varghese P.J., et al. Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 2004, 24:1266-1271.
16. Kalinina N., Agrotis A., Antropova Y., DiVitto G., Kanellakis P., Kostolias G., et al. Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines. Arterioscler Thromb Vasc Biol 2004, 24:2320-2325.
17. Porto A., Palumbo R., Pieroni M., Aprigliano G., Chiesa R., Sanvito F., et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein. FASEB J 2006, 20:2565-2566.
18. Harja E., Bu D.X., Hudson B.I., Chang J.S., Shen X., Hallam K., et al. Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice. J Clin Invest 2008, 118:183-194.
19. Bierhaus A., Nawroth P.P. Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications. Diabetologia 2009, 52:2251-2263.
20. Chaulet H., Desgranges C., Renault M.A., Dupuch F., Ezan G., Peiretti F., et al. Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ Res 2001, 89:772-778.
21. Weisman G.A., Ajit D., Garrad R., Peterson T.S., Woods L.T., Thebeau C., et al. Neuroprotective roles of the P2Y(2) receptor. Purinergic Signal 2012, 8:559-578.
22. Schwartz S.M. Perspectives series: cell adhesion in vascular biology. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 1997, 99:2814-2816.
23. Hao H., Gabbiani G., Bochaton-Piallat M.L. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol 2003, 23:1510-1520.
24. Goetze S., Xi X.P., Kawano Y., Kawano H., Fleck E., Hsueh W.A., et al. TNF-alpha-induced migration of vascular smooth muscle cells is MAPK dependent. Hypertension 1999, 33(1 Pt 2):183-189.
25. Montezano A.C., Callera G.E., Yogi A., He Y., Tostes R.C., He G., et al. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways. Arterioscler Thromb Vasc Biol 2008, 28:1511-1518.
26. Lin C.C., Lin W.N., Wang W.J., Sun C.C., Tung W.H., Wang H.H., et al. Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-kB. Cardiovasc Res 2009, 82:522-531.
27. Vitiello L., Gorini S., Rosano G., la Sala A. Immunoregulation through extracellular nucleotides. Blood 2012, 120:511-518.
28. Di Virgilio F., Solini A. P2 receptors: new potential players in atherosclerosis. Br J Pharmacol 2002, 135:831-842.
29. Ahmad S., Ahmad A., Ghosh M., Leslie C.C., White C.W. Extracellular ATP-mediated signaling for survival in hyperoxia-induced oxidative stress. J Biol Chem 2004, 279:16317-16325.
30. 2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. Proc Natl Acad Sci U S A 1997, 94:831-836.
31. Turner J.T., Park M., Camden J.M., Weisman G.A. Salivary gland nucleotide receptors. Changes in expression and activity related to development and tissue damage. Ann N Y Acad Sci 1998, 842:70-75.
32. Pillois X., Chaulet H., Belloc I., Dupuch F., Desgranges C., Gadeau A.P. Nucleotide receptors involved in UTP-induced rat arterial smooth muscle cell migration. Circ Res 2002, 90:678-681.
33. Bagchi S., Liao Z., Gonzalez F.A., Chorna N.E., Seye C.I., Weisman G.A., et al. The P2Y2 nucleotide receptor interacts with alphav integrins to activate Go and induce cell migration. J Biol Chem 2005, 280:39050-39057.
34. 2R activation by nucleotides released from oxLDL-treated endothelial cells (ECs) mediates the interaction between ECs and immune cells through RAGE expression and reactive oxygen species production. Free Radic Biol Med 2014, 69C:157-166.
35. Hofmann M.A., Drury S., Fu C., Qu W., Taguchi A., Lu Y., et al. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell 1999, 97:889-901.
36. Park L., Raman K.G., Lee K.J., Lu Y., Ferran L.J., Chow W.S., et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 1998, 4:1025-1031.
37. Taguchi A., Blood D.C., del Toro G., Canet A., Lee D.C., Qu W., et al. Blockade of RAGE-amphoterin signaling suppresses tumour growth and metastases. Nature 2000, 405:354-360.
38. Leclerc E., Fritz G., Vetter S.W., Heizmann C.W. Binding of S100 proteins to RAGE: an update. Biochim Biophys Acta 1793, 2009:993-1007.
39. Yan S.D., Chen X., Fu J., Chen M., Zhu H., Roher A., et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 1996, 382:685-691.
40. Deane R., Du Yan S., Submamaryan R.K., LaRue B., Jovanovic S., Hogg E., et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 2003, 9:907-913.
41. Sturchler E., Galichet A., Weibel M., Leclerc E., Heizmann C.W. Site-specific blockade of RAGE-Vd prevents amyloid-beta oligomer neurotoxicity. J Neurosci 2008, 28:5149-5158.
42. McDonald D.R., Bamberger M.E., Combs C.K., Landreth G.E. beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J Neurosci 1998, 18:4451-4460.
43. Dollery C.M., McEwan J.R., Henney A.M. Matrix metalloproteinases and cardiovascular disease. Circ Res 1995, 77:863-868.
44. Zhu P., Ren M., Yang C., Hu Y.X., Ran J.M., Yan L. Involvement of RAGE, MAPK and NF-κB pathways in AGEs-induced MMP-9 activation in HaCaT keratinocytes. Exp Dermatol 2012, 21:123-129.